The prediction of growth-inhibitory drug combinations showing enhanced differential toxicity and collateral sensitivity.
D000970:Antineoplastic Agents; D004338:Drug Combinations; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D004358:Drug Therapy; D006801:Humans
D000970:Antineoplastic Agents; D004338:Drug Combinations
ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY